Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Form 8.3 - Link Fund Solutions Ltd: Midatech Pharma PLC
Form 8.3 - Link Fund Solutions Ltd: Midatech Pharma PLC
Form 8.3 - Link Fund Solutions Ltd: Midatech Pharma PLC
eqs_en 
0 09.06.20
Form 8.3 - Link Fund Solutions Ltd: Midatech Pharma Plc
Form 8.3 - Link Fund Solutions Ltd: Midatech Pharma Plc
Form 8.3 - Link Fund Solutions Ltd: Midatech Pharma Plc
eqs_en 
0 22.04.20
Edison Investment Research Limited: Edison issues update on Silence Therapeutics (SLN)
Edison Investment Research Limited: Edison issues update on Silence Therapeutics (SLN)
Edison Investment Research Limited: Edison issues update on Silence Therapeutics (SLN)
eqs_en 
0 17.04.20
Hardman & Co Research: Diurnal (DNL): $52.5m US deal strengthens balance sheet further
Hardman & Co Research: Diurnal (DNL): $52.5m US deal strengthens balance sheet further
Hardman & Co Research: Diurnal (DNL): $52.5m US deal strengthens balance sheet further
eqs_en 
0 30.03.20
Edison Investment Research Limited: Edison issues update on Silence Therapeutics (SLN)
Edison Investment Research Limited: Edison issues update on Silence Therapeutics (SLN)
Edison Investment Research Limited: Edison issues update on Silence Therapeutics (SLN)
eqs_en 
0 25.03.20
Edison Investment Research Limited: Edison issues initiation on Ergomed (ERGO)
Edison Investment Research Limited: Edison issues initiation on Ergomed (ERGO)
Edison Investment Research Limited: Edison issues initiation on Ergomed (ERGO)
eqs_en 
0 25.03.20
Hardman & Co Research: Allergy Therapeutics (AGY): Consistent first-half revenue growth
Hardman & Co Research: Allergy Therapeutics (AGY): Consistent first-half revenue growth
Hardman & Co Research: Allergy Therapeutics (AGY): Consistent first-half revenue growth
eqs_en 
0 09.03.20
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
eqs_en 
0 28.02.20
Hardman & Co Research: Diurnal (DNL): . and more to come (news flow)
Hardman & Co Research: Diurnal (DNL): . and more to come (news flow)
Hardman & Co Research: Diurnal (DNL): . and more to come (news flow)
eqs_en 
0 28.02.20
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
eqs_en 
0 27.02.20
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
eqs_en 
0 26.02.20
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
eqs_en 
0 25.02.20
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
eqs_en 
0 24.02.20
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
eqs_en 
0 21.02.20
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
eqs_en 
0 19.02.20
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
eqs_en 
0 17.02.20
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
eqs_en 
0 13.02.20
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
eqs_en 
0 12.02.20
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
eqs_en 
0 11.02.20
Hardman & Co Research: Tissue Regenix (TRX): Restructured to satisfy product demand
Hardman & Co Research: Tissue Regenix (TRX): Restructured to satisfy product demand
Hardman & Co Research: Tissue Regenix (TRX): Restructured to satisfy product demand
eqs_en 
0 06.02.20
Hardman & Co Research: genedrive plc (GDR): Western market progress but developing markets difficult
Hardman & Co Research: genedrive plc (GDR): Western market progress but developing markets difficult
Hardman & Co Research: genedrive plc (GDR): Western market progress but developing markets difficult
eqs_en 
0 05.02.20
Form 8.3 - The Vanguard Group, Inc.: Consort Medical plc
Form 8.3 - The Vanguard Group, Inc.: Consort Medical plc
Form 8.3 - The Vanguard Group, Inc.: Consort Medical plc
eqs_en 
0 23.01.20
Hardman & Co Research: Allergy Therapeutics (AGY): Sales growth well above market average
Hardman & Co Research: Allergy Therapeutics (AGY): Sales growth well above market average
Hardman & Co Research: Allergy Therapeutics (AGY): Sales growth well above market average
eqs_en 
0 16.01.20
Edison Investment Research Limited: Edison issues initiation on Silence Therapeutics (SLN)
Edison Investment Research Limited: Edison issues initiation on Silence Therapeutics (SLN)
Edison Investment Research Limited: Edison issues initiation on Silence Therapeutics (SLN)
eqs_en 
0 09.01.20
Form 8.3 - The Vanguard Group, Inc.: Consort Medical plc
Form 8.3 - The Vanguard Group, Inc.: Consort Medical plc
Form 8.3 - The Vanguard Group, Inc.: Consort Medical plc
eqs_en 
0 26.12.19